Deep brain stimulation is referred to a surgery that includes implantation of an electrical device in the body. The device sends electrical signals to the areas of brain that are responsible for body movement. These devices are utilized for treating various neurological disorders, such as epilepsy, dystonia, Parkinson's disease, essential tremor and obsessive compulsive disorder, among others.
This report contains market size and forecasts of Deep Brain Stimulation Systems in global, including the following market information:
Global Deep Brain Stimulation Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Deep Brain Stimulation Systems Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Deep Brain Stimulation Systems companies in 2021 (%)
The global Deep Brain Stimulation Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single-Channel Deep Brain Stimulator Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Deep Brain Stimulation Systems include Boston Scientific Corporation, Fisher Wallace, SceneRay Corporation, Aleva Neurotherapeutics, Medtronic, Abbott and Beijing PINS Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Deep Brain Stimulation Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Deep Brain Stimulation Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Deep Brain Stimulation Systems Market Segment Percentages, by Type, 2021 (%)
Single-Channel Deep Brain Stimulator
Dual-Channel Deep Brain Stimulator
Global Deep Brain Stimulation Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Deep Brain Stimulation Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers (ASCs)
Neurological Clinic
Global Deep Brain Stimulation Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Deep Brain Stimulation Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Deep Brain Stimulation Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Deep Brain Stimulation Systems revenues share in global market, 2021 (%)
Key companies Deep Brain Stimulation Systems sales in global market, 2017-2022 (Estimated), (Units)
Key companies Deep Brain Stimulation Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific Corporation
Fisher Wallace
SceneRay Corporation
Aleva Neurotherapeutics
Medtronic
Abbott
Beijing PINS Medical